Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | F2 | P00734 | 2/20 | 0.62 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.62 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.62 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 5/20 | 0.53 |
| ▸ | CA2 | P00918 | 5/20 | 0.53 |
| ▸ | CA5A | P35218 | 5/20 | 0.53 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL735400 | 1.00 | KMT2A (0.68) | KMT2AALDH1A1F2PRSS1PRSS2 | |
| SCHEMBL31689627 | 1.00 | KMT2A (0.68) | KMT2AALDH1A1F2PRSS1PRSS2 | |
| SCHEMBL3782036 | 1.00 | KMT2A (0.68) | KMT2AALDH1A1F2PRSS1PRSS2 | |
| SCHEMBL20729441 | 1.00 | KMT2A (0.68) | KMT2AALDH1A1F2PRSS1PRSS2 | |
| SCHEMBL1500774 | 1.00 | KMT2A (0.68) | KMT2AALDH1A1F2PRSS1PRSS2 | |
| SCHEMBL12706679 | 1.00 | KMT2A (0.68) | KMT2AALDH1A1F2PRSS1PRSS2 | |
| SCHEMBL23124424 | 1.00 | KMT2A (0.68) | KMT2AALDH1A1F2PRSS1PRSS2 | |
| SCHEMBL10000728 | 0.85 | KMT2A (0.70) | KMT2AALDH1A1F2PRSS1PRSS2 | |
| SCHEMBL5960692 | 0.85 | KMT2A (0.70) | KMT2AALDH1A1F2PRSS1PRSS2 | |
| SCHEMBL1362019 | 0.85 | KMT2A (0.70) | KMT2AALDH1A1F2PRSS1PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112029041-B | Preparation method and application of porous silicon-based microspheres loaded with poly (propargyl) helical polymer | 哈尔滨工程大学 | 2021-05-18 | — | — | CN | claimed |
| CN-112029041-A | Preparation method and application of porous silicon-based microspheres loaded with poly (propargyl) helical polymer | 哈尔滨工程大学 | 2020-12-04 | — | — | CN | claimed |
| WO-2025122953-A1 | DOSING REGIMENS AND FORMULATIONS OF SUZETRIGINE FOR USE IN THE TREATMENT OF ACUTE AND CHRONIC PAIN | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2025-06-12 | — | — | WO | disclosed |
| US-20250186419-A1 | DOSING REGIMENS FOR TREATING PAIN | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2025-06-12 | — | — | US | disclosed |
| EP-3917907-B1 | MODULATORS OF POTASSIUM ION CHANNELS AND USES THEREOF | UNIV DEGLI STUDI DI SALERNO (IT) | 2025-05-21 | — | — | EP | disclosed |
| US-20250115687-A1 | PRODUCTION METHOD FOR SOLID CATALYST COMPONENT FOR POLYMERIZING OLEFINS, AND CATALYST FOR POLYMERIZAING OLEFINS | FORMOSA PLASTICS CORP USA (US) | 2025-04-10 | — | — | US | disclosed |
| US-20240253023-A1 | PERFLUORINATED AMIDE SALTS AND THEIR USES AS IONIC CONDUCTING MATERIALS | MICHOT CHRISTOPHE (FR) | 2024-08-01 | — | — | US | disclosed |
| CN-111225896-B | Immunomodulatory compounds | 凯莫森特里克斯股份有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-117164587-A | Ester group-containing substituted evodiamine derivative, preparation method and application | 南华大学附属第一医院 | 2023-12-05 | — | — | CN | disclosed |
| CN-116874532-A | High-efficiency preparation method and application of 4-hydrobenzo [1,2] azaphosphine-3-ketone-1-oxide series compound | 浙大城市学院 | 2023-10-13 | — | — | CN | disclosed |
| US-11708326-B2 | Immunomodulator compounds | CHEMOCENTRYX, INC. (US) | 2023-07-25 | — | — | US | disclosed |
| WO-1998000395-A1 | PHENYLALAMINE DERIVATIVES AS INTEGRIN INHIBITORS | MERCK PATENT GMBH (DE) | 1998-01-08 | — | — | WO | disclosed |
| EP-0777660-A1 | NOVEL ALKYLAMINO DERIVATIVES AS SIGMA 2 SELECTIVE LIGANDS | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-06-11 | — | — | EP | disclosed |
| EP-0654028-B1 | 3- AND 5-SUBSTITUTED 1,2,3,4-OXATRIAZOLE-5-IMINE COMPOUNDS, A PROCESS FOR THE PREPARATION THEREOF, A PHARMACEUTICAL PREPARATION CONTAINING SAID COMPOUNDS AND THE USE OF SAID COMPOUNDS FOR THE PREPARATION OF MEDICAMENTS | GEA FARMACEUTISK FABRIK AS (DK) | 1996-04-17 | — | — | EP | disclosed |
| WO-1996005185-A1 | NOVEL ALKYLAMINO DERIVATIVES AS SIGMA 2 SELECTIVE LIGANDS | MITSUBISHI CHEMICAL CORPORATION (JP) | 1996-02-22 | — | — | WO | disclosed |
| US-5424306-A | Storage stable | SANKYO COMPANY, LIMITED (JP) | 1995-06-13 | — | — | US | disclosed |
| US-5352822-A | Insecticides; miticides; nematocides | ROUSSEL UCLAF (FR) | 1994-10-04 | — | — | US | disclosed |
| US-5229424-A | Insecticides, acaricides | THE WELLCOME FOUNDATION LIMITED (GB) | 1993-07-20 | — | — | US | disclosed |
| US-5175159-A | Prevention of premature labor | MERCK & CO., INC. (US) | 1992-12-29 | — | — | US | disclosed |
| EP-0421802-A2 | 3-substituted-1,4-benzodiazepines useful as oxytocin antagonists | MERCK & CO. INC. (US) | 1991-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11708326-B2 | Immunomodulator compounds | IL2, FCGRT, IFNG | KMT2A 2193/4885ALDH1A1 877/4885F2 677/4885 |
| US-20250186419-A1 | DOSING REGIMENS FOR TREATING PAIN | OPRL1, OPRK1, TRPV1 | KMT2A 3847/4885ALDH1A1 413/4885F2 3346/4885 |
| US-20240253023-A1 | PERFLUORINATED AMIDE SALTS AND THEIR USES AS IONIC CONDUCTING MATERIALS | AFF4, AFF2, AFF1 | KMT2A 1243/4885ALDH1A1 1811/4885F2 197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.